Stay updated on Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.5.4' was added to the record history, replacing the earlier 'Revision: v3.5.3'. This indicates a new version of the page has been published in the history.
    Difference
    0.1%
    Check dated 2026-05-15T09:18:35.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    This update reflects a minor website/app revision change for ClinicalTrials.gov (version number increment), with no new or removed information in the trial’s record history table.
    Difference
    0.1%
    Check dated 2026-04-24T05:52:47.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:32:21.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and v3.4.3 was removed; the record now shows updates to Recruitment Status and Study Status.
    Difference
    0.1%
    Check dated 2026-03-19T06:07:52.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added a new Revision: v3.4.3 to the record history and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:49:28.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history and a government operating-status notice was removed; no core study data or status information was modified.
    Difference
    0.9%
    Check dated 2026-02-11T12:34:26.000Z thumbnail image

Stay in the know with updates to Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.